Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /GRIN
chevron_leftBack

Grown Rogue International Inc.

GRIN
CSE: GRIN Delayed
0.5400CAD -1.8%
0.3891 USD
As of 24 April 2025, Grown Rogue International Inc. has a market cap of $88.63M USD, ranking #21259 globally and #3422 in the United States. It ranks #2120 in the Healthcare sector, and #480 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
21259
Country Rank
3422
Sector Rank
2120
Industry Rank
480
Key Stats
Market Cap
$88.63MUSD
122.74M CAD
Enterprise Value
$93.69MUSD
130.02M CAD
Revenue (TTM)
$28.07MUSD
38.87M CAD
EBITDA (TTM)
$2.14MUSD
2.96M CAD
Net Income (TTM)
-$11.74MUSD
-16.26M CAD
EBITDA Margin
7.6%
Profit Margin
-42%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
J. Strickler open_in_new
Founded
1978
Website
grownrogue.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.8% -6.9% -27% -38% -40% -40%
Upcoming Earnings
Earnings Date
Wed, Apr 30

Markets

Exchange Ticker Price
Canadian Securities Exchange
MIC: XCNQ
PRIMARY
GRIN
Grown Rogue International Inc Ordinary Shares (Sub Voting)
ISIN: CA39986R3045
Shares Out.:
246.853M1 Shares Float: 133.066M2
TV:
SA:
YF:
GF:
BA:
MS:
0.5400 CAD
Cboe Canada
MIC: NEOE
GRIN
Grown Rogue International Inc Ordinary Shares (Sub Voting)
ISIN: CA39986R3045
TV:
SA:
YF:
GF:
BA:
MS:
0.5000 CAD
OTC Markets
MIC: OTCM
GRUSF
Grown Rogue International Inc Ordinary Shares (Sub Voting)
ISIN: CA39986R3045
TV:
SA:
YF:
GF:
BA:
MS:
0.3600 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Grown Rogue International Inc.

Grown Rogue International Inc., a craft cannabis company, focuses on premium flower and flower-derived products. It produces a range of cultivars for consumers, which are classified as indicas, sativas, and hybrids. The company sells its products through dispensaries. Grown Rogue International Inc. was incorporated in 1978 and is headquartered in Medford, Oregon.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
76K%
United Therapeutics Corp.
UTHR
$13.18B
15K%
Neurocrine Biosciences, Inc.
NBIX
$10.21B
11K%
Viatris Inc.
VTRS
$9.32B
10K%
Lantheus Holdings, Inc.
LNTH
$6.94B
8K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Merck KGaA
MRK
$59.42B
52.43B EUR
67K%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
55K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
52K%
Haleon plc
HLN
$45.57B
34.34B GBP
51K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
26K%